Literature DB >> 24934079

Coexistence of radioactive iodine-resistant benign struma ovarii with cervical primary papillary cancer of the thyroid: an unusual cause of thyroglobulin-positive radioactive iodine-negative whole-body scans.

Vahab Fatourechi1, John C Morris, Thomas J Sebo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24934079      PMCID: PMC4516955          DOI: 10.1089/thy.2014.0010

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  5 in total

1.  Incidental diagnosis of struma ovarii detected with 99mTc SPECT/CT.

Authors:  Mehmet Mulazimoglu; Muge Oner Tamam; Tevfik Ozpacaci; Duzgun Yildirim; Seyma Ekmekci; Deniz Ozcan; Senay Erdogan
Journal:  Clin Nucl Med       Date:  2012-03       Impact factor: 7.794

2.  Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.

Authors:  Athanasios D Anastasilakis; Rosaria-Maddalena Ruggeri; Stergios A Polyzos; Polyzois Makras; Dimitra Molyva; Alfredo Campennì; Athina Gkiomisi; Christos Balaris; Panagiotis P Fotiadis; Giovanni Tuccari; Stergios Papachatzopoulos
Journal:  Metabolism       Date:  2013-06-24       Impact factor: 8.694

Review 3.  Increased serum thyroglobulin levels and negative imaging in thyroid cancer patients: are there sources of benign secretion? A speculative short review.

Authors:  Paolo Zanotti-Fregonara; Isabelle Keller; Marie Calzada-Nocaudie; Adil Al-Nahhas; Jean-Yves Devaux; Gaia Grassetto; Maria Cristina Marzola; Domenico Rubello; Elif Hindié
Journal:  Nucl Med Commun       Date:  2010-12       Impact factor: 1.690

4.  Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.

Authors:  Aaron Leong; Philip J R Roche; Miltiadis Paliouras; Louise Rochon; Mark Trifiro; Michael Tamilia
Journal:  J Clin Endocrinol Metab       Date:  2013-11-11       Impact factor: 5.958

5.  Clinical characteristics of struma ovarii.

Authors:  Seung-Chul Yoo; Ki-Hong Chang; Mi-Ok Lyu; Suk-Joon Chang; Hee-Sug Ryu; Haeng-Soo Kim
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.